Cathie Wood highlights health care as key area for AI advancements
cnbc.com — February 4, 2025, 08:00 PM UTC
Cathie Wood of Ark Invest highlights health care as a key area for artificial intelligence, noting its potential for significant advancements. She believes AI can enhance data storage and drug discovery, particularly through her investment in Recursion Pharmaceuticals. Recursion recently received FDA approval for phase 1 trials of an AI-discovered cancer treatment. The company has improved its research capabilities significantly, leading to a nearly 10% increase in its stock this year after a previous decline. Wood is shifting her focus from hardware to software in AI investments, with Palantir as a top pick. The company's shares rose 24% after reporting strong results, driven by AI growth in both commercial and government sectors.